ANTI-INFLAMMATORY ACTIVITIES OF PHYSALIN A
FROM
PHYSALIS ANGULATA
THROUGH THE
INHIBITION OF MMP-9, NF-
ΚB, AND MAPK
ACTIVATION
IN VITRO
AND
IN VIVO
WEN-TSONG, HSIEH
文
聰
謝
Department of Pharmacology,
School of Medicine,
China Medical University
Taichung, Taiwan
2012.11.15
GSU/CMU Biotech symposium 2012
First part
Anti-cancer research
in Our Lab
Background of our lab. in anti-cancer research
Risk factors of Oral Cancer
•
Betel nut
•
Tobacco
•
Alcohol
•
Diet and nutrition,
•
Ultraviolet light,
•
HPV infection
(the Institute of Medicine, 2007)
(J Oral Pathol Med, 1989)
(Global cancer statistics, 2002)
(Ann Oncol, 2003)
4
Michael Ericksen
Dean, institute of public Health
5
Anticancer research in TCM and folk herbs
1. 山芙蓉 Hibiscus taiwanensis
2.山豆根 Sophora subprostrata
3. 龍葵 Solanum nigrum
4. 香茅 Cymbopogon citratus
5. 艾草 Artemisia indica
6. 一枝黃花 Solidago decurrens
7. 鉤藤 Viburnum odoratissimum
8. 苦蘵 Physalis angulata
9. 金剛纂 Euphorbia antiquorum
10………
2001 Lee et al., Effects and mechanisms of PAon cell death in human lung squamous cell carcinoma. 2001 Lee et al., Effects and mechanisms of PAon cell death in human lung squamous cell carcinoma. 1992 Chiang et al., Inhibitory effects of physalin B and physalin F on varioushuman leukemia cells
in vitro. 1992 Chiang et al., Inhibitory effects of physalin B and physalin F on various
human leukemia cells
in vitro. 2002 Kuo et al., The antiproliferative activity of PAis through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines.
2002 Kuo et al., The antiproliferative activity of PAis through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines.
2001 Ismail et al., A novel cytotoxic flavonoid glycoside from Physalis angulata. 2001 Ismail et al., A novel cytotoxic flavonoid glycoside from Physalis angulata. 2004 Wu et al., Antihepatoma activity of PA
and P. peruviana extracts and their
effects on apoptosis in human Hep G2 cells.
2004
Wu et al.,
Antihepatoma activity of PA
and P. peruviana extracts and their
effects on apoptosis in human Hep G2 cells. 2003 Makino et al., Cytotoxic activity of physalinspossessing modified skeletal structures against HeLa cells. 2003 Makino et al., Cytotoxic activity of physalinspossessing modified skeletal structures against HeLa cells. 2001s 1992s 2005 Vieira AT et al., Mechanisms of the anti-inflammatoryeffects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury.
2005
Vieira AT et al., Mechanisms of the anti-inflammatoryeffects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury.
2006
Magalhs HI, et al.,
In-vitroand in-vivo antitumour activityof physalins B and D from Physalis angulata.
2006
Magalhs HI, et al.,
In-vitroand in-vivo antitumour activityof physalins B and D from Physalis angulata.
2007 Castro DP et al., Immune depression in Rhodnius prolixus by seco-steroids, physalins. 2007 Castro DP et al., Immune depression in Rhodnius prolixus by seco-steroids, physalins. 2002s 2003s 2004s 2005s 2006-2011 2012s2007s
Physalis angulata
(Solanaceae)
Usage: Herb tea
涼茶
(清涼退火)
Extinguish the fire inside the body
7
8
Isolation physalins from
physalis angulata
Methods
Morphology
MTT assay
Cell cycle analysis (Flow
cytometry) Western blot
1. Proliferation
3. Metastasis
Migration assay
-
Wound healing assay
-
Transwell migration assay
Matrigel invasion assay
Confoal image
Western blot
2. Apoptosis
Flow cytometry
-
Ca
++production
-
Mitochondrial membrane potential (∆Ψ
DAPI stain
DNA ladder assay
Western blot
Physalin A on cell cycle analysis by flow cytometer
Physalin A induced G2/M arrest and apoptosis in HSC-3 cells in
dose & time dependent.
Result-G2/M arrest & apoptosis
3.13 µM 6.25 µM 12.5 µM 17 control 0.78 µM 1.56 µM HSC-3 cell Physalin A [uM] Control0.39 0.78 1.56 3.13 6.25 12.5 C e ll n u m b er ( % ) 0 10 20 30 40 50 60 70 80 G0/G1 G2/M S Apoptosis cdc2 60kDa 0 0.39 0.78 1.56 3.13 6.25 12.5 (µM) 58kDa 53kDa 27kDa 34kDa cyclinB1 cyclinA p53 p27 42kDa Actin Wee1 105kDa
HSC-3
PA 1.0 0.5 0.3 0.4 0.5 0.5 0.7 1.0 0.9 0.8 0.7 0.6 0.6 0.2 1.0 1.2 1.1 1.2 1.1 0.9 0.9 1.0 0.6 0.4 0.6 0.7 1.0 1.1 1.0 1.5 1.7 1.9 1.8 2.0 2.0 1.0 0.5 0.3 0.3 0.2 0.3 0.1Physalin A
induced G2/M arrest
with
decreasing cyclin A, cyclin B1
and
cdc2
activity, but
increasing wee1, p27
and
p53
levels.
G2/M phase arrest
cyclinA/B1
P
p53
PAWee1
p27
Physalin A on G2/M phase of cell cycle relative proteins
19
Result-G2/M arrest
13
Effects of PA on mRNA expression of cyclin
A and cyclin B1 in HSC-3 cells.
Physalin A
induced G2/M arrest
with
decreasing mRNA expression in
cyclin A
levels, dose dependently .
Methods
Morphology
MTT assay
Cell cycle analysis (Flow
cytometry) Western blot
1. Proliferation
3. Metastasis
Migration assay
-
Wound healing assay
-
Transwell migration assay
Matrigel invasion assay
Confoal image
Western blot
2. Apoptosis
Flow cytometry
-
Ca
++production
-
Mitochondrial membrane potential (∆Ψ
DAPI stain
DNA ladder assay
Western blot
(µM)
500 bp
400 bp
200 bp
100 bp
300 bp
To analyze the DNA
fragmentation, HSC-3 cells were
treated with Physalin A for 24 hr.
Fragmented DNA was extrcted
and analyzed on 2 % agarose gel
electrophoresis with containing
EtBr.
Physalin A could induced
DNA
damage with DNA ladder assay
(apoptosis) in HSC-3 cells.
Physalin A on DNA damage with DNA ladder assay
Result-DNA fragmentation
2 6
Cells were harvested after 24 h of PA treatment. After fixing, the
cells were stained with DAPI. Stained nuclei were then observed
under a fluorescent mircroscope.
PA induced DNA condensation in
HSC-3 cells.
Effects of PA on DNA condensation with DAPI stain
3.13 µM
6.25 µM
12.5 µM
control
0.39 µM
0.78 µM
1.56 µM
200 x 2 4(Negative control)
0.39 µM
0.78 µM
1.56 µM
DMSO
(positive control)
5 µM H
2O
2Physalin A on DNA damage by Comet assay
HSC-3 cells were treated
with Physalin A (0.39, 0.78,
1.56 µg/ml) for 24 hr and
applied to
Single cell
electrophoresis
Physalin A induced DNA
damage dose dependent by
the Comet assay in HSC-3
cells
Result-DNA damage Phsalin A [µg/ml] T a il momen t (%) 2 8Effects of PA-42 on Ca
2+
production by flow cytometry
Result-Ca 2+production
24 hr
0 hr
1 hr
6 hr
12 hr
6 hr
0 hr 1 hr 6 hr 12 hr 18 hr 24 hr Time (hr) Ca 2+ p roduction (%) 21Cells were harvested
various hour of PA
PA-42 could increase
Ca
++production at 6-12
Measurement of mitochondrial membrane potential (∆Ψ
m
)
Ca
2+was determined by Indo 1/AM flow cytometry.
Mitochondrial energization was determined by the retention of the dye
DiOC
63'-dihexyloxacarbocyanine iodide
flow cytometry.
2 0
Method-Ca2+and MMPanalysis
Measurement of Ca
2+
(Cell Death Differ, 2007)
pro-casp-3 17kDa 32kDa Bcl-2 26kDa 0 0.39 0.78 1.56 3.13 6.25 12.5 (µM) AIF 57kDa Actin 42kDa 21kDa Bax Bid Fas 40kDa 22kDa PA cleaved casp-3 1.0 2.2 2.9 5.3 6.8 7.1 7.1 1.0 1.5 1.8 2.1 2.2 2.1 2.1 1.0 1.2 1.3 1.4 1.2 1.1 0.9 1.0 0.9 0.7 0.8 0.8 0.8 0.8 1.0 1.0 1.0 1.1 1.0 1.0 1.0 1.0 1.1 1.1 1.3 1.3 1.5 1.2 1.0 1.1 1.1 1.4 1.7 1.9 1.9 HSC-3
Physalin A
triggered apoptosis
with an
increase in Fas, Bax, Bid,
and cleaved caspase-3
but
a decrease in Bcl-2.
Fas
Ca
2+Bax Bid
Apoptosis
Bcl-2
pro-caspase-3
cleaved caspase-3
PAMMP
(∆Ψm)
AIF
Ca
2+Effects of Physalin A on apoptotic proteins
AIF: apoptosis-inducing factor MMP : mitochondrial membrane
i l
2 9
Result- Apoptosis proteins
21
Channels (FL2-A) 0 50 100 150 200 250 0 50 100 150 200 Channels (FL‐2) Num b er 100 200 300 400 PA 6.0 μM Pifithrin-α 20 μM Channels (FL2-A) 0 40 80 120 160 200 0 50 100 150 200 Channels (FL‐2) Num b er 100 200 300 400 PA 6.0 μM Pifithrin-α 40 μM Channels (FL2-A) 0 50 100 150 200 250 0 50 100 150 200 Channels (FL‐2) Num b er 100 200 300 400 PA 6.0 μM Pifithrin-α 10 μM Channels (FL2-A) 0 40 80 120 160 200 0 50 100 150 200 Channels (FL‐2) Num b er 100 200 300 400 PA 6.0 μM Pifithrin-α 80 μM PA 6.0 μM Pifithrin-α 0 μM Num b er 100 200 300 400 0 50 100 150 200 250 0 50 100 150 200 Channels (FL‐2) PA 0 μM Pifithrin-α 0 μM Channels (FL2-A) 0 40 80 120 160 200 0 50 100 150 200 Channels (FL‐2) Num b er 100 200 300 400 PA 6.0 μM - + + + + + - - 10 20 40 80 PTF-α (μΜ ) C ell num ber (% ) 0 10 20 30 40 50 60 70 G0/G1 phase G2/Mphase S phase Apoptosis a a b b a b a a b bPA on 2D-gel
Protein Name Accession Number pI MW (Da)
264 Heat shock 70kDa protein 8 [Homo
sapiens]
gi|16741727 5.37 70854
268 HSP70-2 [Homo sapiens] gi|4529892 5.48 69982
RESULT –HSP
264
268
HSP90
HSP70-2
β-actin
90 kDa
40 kDa
42 kDa
2.58
1.97
1.80
1.04
1.00
1.11
1.11
1.13
0.95
1.00
PA(μM)
0 1.6 3.1 6.3 12.5
Methods
Morphology
MTT assay
Cell cycle analysis (Flow
cytometry) Western blot
1. Proliferation
3. Metastasis
Migration assay
-
Wound healing assay
-
Transwell migration assay
Matrigel invasion assay
Confoal image
Western blot
2. Apoptosis
Flow cytometry
-
Ca
++production
-
Mitochondrial membrane potential (∆Ψ
DAPI stain
DNA ladder assay
Western blot
PA in 2D-gel analysis
Protein Name Accession Number pI MW (Da)
352 alpha-tubulin [Homo sapiens] gi|340021 4.94 50120
369 Tubulin, beta [Homo sapiens] gi|14043231 4.78 49639
480 Nucleophosmin (nucleolar
phosphoprotein B23, numatrin) [Homo sapiens]
gi|16876872 4.64 32555
352
480
369
Effects of PA-42 on
cell migration
by wound healing assay
PA-42
inhibited wound healing
significant
&
without cytotoxicity.
Result-wound healing migration
Serum-free medium for 24 hr Seeding cells wound Migration PA-42 33 Time (hr) Wo und range (µm )
Result-transwell migration assay
0.39 µg/ml
0.78 µg/ml
1.56 µg/ml
control
Upper chamber (1%FBSmedium) Lower chamber (10% FBS medium) Basement membrane layerCrystal violet Staining
Physalin A for 24 hr inhibited ~50% migration
without significant cytotoxicity HSC-3 cells
PA Concentration (µM) In h ib ition rate (% of co n tro l) 3 4
Physalin A on cell migration by Transwell Migration assay
Effects of PA 0.75~1.56 µM on matrigel invasion assay
Result-matrigel invasion assay
Upper chamber (1%FBS medium)
Lower chamber (10%FBSmedium) Coated 50 µl matrigel
Crystal violet Staining
HSC-3 cells at
IC
10dose of PA for 24 hr
inhibited ~35% invasion
without
significant cytotoxicity by the ImageJ
freeware analyzed.
PAcontrol
0.39 µM
0.78 µM
1.56 µM
35 Cell count mean (± SD) Inhibition rate (% of control) Control 782.33 (± 34.27) 0% 0.75 617.67 (± 55.99) 21.05% 1.5 536.33 (± 17.93) 31.44% 3 497.67 (± 4.04) 36.39% 0 0.39 0.78 1.56 PA [μM] In vasio n cell s (% ) 0 200 400 600 800 0 0.39 μM 0.78 μM 1.56 μM * ** ***Red : ®-Actin (rhodamine) Blue : DAPI (DNA stain) control
merge merge
Physalin A 1.56 µg/ml
Physalin
reversed cytoskeleton
from
mesenchymal-like
to
epithelial-like
with
increased E-cadherin (epithelial marker)
and
decreased α-smooth muscle
actin (mesenchymal marker ) in HSC-3 cells.
Green : E-cadherin (FITC) Blue : DAPI (DNA stain) control
merge merge
Physalin A 1.56 μg/ml
Green : α-smooth muscle actin (FITC) Blue : DAPI(DNA stain) control
merge merge
Physalin A 1.56 μg/ml
Physalin A on metastasis relative proteins by confocal image
culture slides Cells PA cancer cell 2 2 confocol microscope (630x) 3 6 Result-cytoskeleton proteins 0 0.39 0.78 1.56 (µM) MMP-2 55kDa β-actin 42kDa GRB2 24kDa HSC-3 PA 1.0 0.7 0.8 0.7 1.0 0.9 0.8 0.7
Physalin A
inhibited metastasis
with a decrease in MMP-3
and GRB2.
Physalin A on metastasis relative proteins
MMP-3 : matrix metalloproteinase-3 GRB2 : growth factor receptor-bound protein 37 Result-metastasis proteins
Epithelial-like
MMP-2
migration
invasion
Mesenchymal-like
E-cadherin
GRB2
α-smooth muscle Actinmetastasis
30Gross and histopathological findings of hamster’s pouch in (7,12-dimethylbenz
[α]anthracene )DMBA Group. Gross of pouches presented tumor masses on the mucosa (A.
closed, B. opened). Microscopically, moderate (3) hyperplasia with moderate (3) dysplasia,
thickness of the epidermal layer (C. 100x, D. 200x, E. 400x). Severe (4) papilloma showed
cauliflower-like growth, elongated and protruded with necrosis from epidermis to form
papillary folding (F. 40x), and moderate (3) multicentric squamous cell carcinoma (SCC)
invaded into the submucosa (G. 100x) and increased mitoses (H. 200x, I. 400x) in the
epidermal epithelium of the pouch, H&E stain.
The effect of Physalin A on Gross and histopathological findings
of hamster’s pouch in DMBA Group
31 E
Gross and histopathological findings of hamster’s pouch in DMBA + PA 50 mg/kg Group.
Gross of pouches presented tumor masses on the mucosa (A. closed, B. opened, animal
code. 202). Microscopically, slight (2) hyperplasia with moderate (3) dysplasia, thickness
of the epidermal layer (C. 100x, D. 200x, E. 400x). Moderate (3) papilloma showed
cauliflower-like growth, elongated and protruded with necrosis from epidermis to form
papillary folding (F. 40x), and no (0) multicentric squamous cell carcinoma (SCC)
invaded into the submucosa (G. 100x) but increased mitoses (H. 200x, I. 400x) in the
epidermal epithelium of the pouch (animal code. 207), H&E stain.
The effect of Physalin A on Gross and histopathological findings
of hamster’s pouch in DMBA Group
32
Physalin A in Hamster pouch tumor expression
Ind
ex
sc
ale
of le
sio
n
s
0
1
2
3
4
Hyperplasia Dysplasia Papilloma Invasive carcinomaDMBA - + + + +
PA mg/kg 0 0 2.5 5.0 7.5
Degrees of lesions
(1= minimal; 2=slight; 3=moderate; 4=severe)
33
AIF: apoptosis-inducing factor MMP-3 : matrix metalloproteinase-3 GRB2 : growth factor receptor-bound protein Comet assay DNA damage p53 CyclinA/B1 Wee1 G2/M phase arrest PA migration invasion metastasis
Epithelial-like Mesenchymal-like
MMP-2 GRB2 α-smooth muscle Actin E-cadherin Apoptosis active cleaved-caspase-3 4 0
Fas
cleaved-caspase-8CAD: caspase activated Dnase ICAD: inhibtor CAD MMP : mitochondrial membrane potential DNA nuclear AIF DNA fragmentation DNA ladder formation CAD inhibitor inactive active DAPI stain DNA condensation cleaved-caspase-9 active AIF Ca2+
mitochondri
a
Ca2+ MMP (∆Ψm) Bcl-2 Bax BidSummary 1
34
Second part
Anti-inflammtory research of PA
by Ya-Sing Hsiau
Undergraduate student study
from 2011/3 to 2012/6
35
36
PA significantly decreased the NO production and
shown low cell cytotoxicity in
RAW
264.8 cells,
but the its mechanism still does not understand.
Cell Viability and the Effect of Physalin A on
LPS-induced NO Production in Macrophages
37
Inflammation Pathway
TLR4
mediators: NO PGs cytokines: IL-1β, IL-6,
TNF-α
Inflammation Pathway
y
TLR4 pathway (
Upstream
)
CD14, MD2, MyD88
y
MAPK pathway
JNK, ERK, p38…
y
IkK, IkB pathway
p-IkK, p-IkB…
y
NF-κB pathway
p50, p65
y
Transcription proteins
(Down
stream):
COX-2, iNOS, MMPs
y
mediators: NO, PGs...
y
cytokines:
IL-1
β, IL-6, TNF-α ...
TLR4
COX-2, iNOS, MMPs
38
y
In this study, we want to
evaluation the
anti-inflammatory effects of
physalin A.
y
In vitro:
using
lipopolysaccharide (LPS)
-stimulated mouse
macrophage
RAW264.7 cells
y
In vivo:
using λ-
carrageenan
(Carr)-induced hind mouse
paw edema model.
Aim
mediators: NO PGs cytokines: IL-1β, IL-6,
TNF-α COX-2, iNOS, MMPs
39
METHODS
In vitro
RAW
cell
MTT assay NO assay ELISA NO Ils TNF Western PCR mediators: NO PGs cytokines: IL-1b, IL-6,TNF-a
In vivo
Mice
Carrageen
an-induced
Paw
Edema
NO assay ELISA NO Ils TNF WesternRESULTS
40
41
Inhibition of LPS-induced iNOS and
COX-2 Protein by Physalin A
Physalin A treatment could down-regulation of iNOS
and COX-2 proteins expression in RAW 264.7 cells.
42
Inhibition of LPS-induced NF-κB
Proteins by Physalin A
Down-regulation of p65 proteins, respectively, after the treatment
with physalin A at 2 µM compared with the LPS-alone.
43
Physalin A Inhibits the levels of I
ΚK ,
I
ΚB Inflammatory Proteins
IKB IK B pro te in ex pre s s ion( %c on tr ol) 0 20 40 60 80 100 120 140 160 180 PAEA(μg/ml) - 0.5 1 2 4 -LPS(100μg/ml) - + + + + + + Indomethasin(10μM) - - - + pERK R el at ive pr ot ei n expr essi on (f o ld of LPS t reat ed gr oup) 0.0 0.2 0.4 0.6 0.8 1.0 1.2 med ACE- 0 ACE-25 ACE-50 ACE-75 ACE-100 # * *pERK
ERK
pJNK R el a ti ve pr ot ei n expr essi on (f o ld of LPS t rea te d gr oup) 0.0 0.2 0.4 0.6 0.8 1.0 1.2 med ACE- 0 ACE-25 ACE-50 ACE-75 ACE-100 * # * * *pJNK
JNK
pp38
p38
β-actin
Effects of Physalin A on the LPS-stimulated
Activation of Mitogen-activated Protein Kinases
(MAPKs)
These results suggest that phosphorylation of MAPKs may be
involved in the inhibitory effect of physalin A on LPS-stimulated
NF-κB binding in RAW 264.7 cells.
45
MMP-9 Pe rc en ta g e ( % ) 0 20 40 60 80 100 120 control PA 0.375 PA 0.75 PA 1.5 PA 3.1 PA 6.25 MMP-9P
er
ce
n
ta
ge
(%
)
0 20 40 60 80 100 120 control PA 0.375 PA 0.75 PA 1.5 PA 3.1 PA 6.25Physalin A-Reduced MMP-2 & MMP-9
expression in zymography and western blotting
Time (hrs) 0 1 2 3 4 5 Δ v ( m l) 0.00 0.02 0.04 0.06 0.08 0.10 Carr
Carr + Indo 10 mg/kg (i.p.) Carr + PAEA 2.5 mg /kg (i.p.) Carr + PAEA 5.0 mg /kg (i.p.) Carr + PAEA 10 mg /kg (i.p.)
*** *** *** ** ** *
Effects of Physalin A on Carr-induced
Mouse Paw Edema
PA significantly decreased the λ-carrageenan induced
paw edema at the 4
th
h and the 5
th
h.
Histopathological findings of
foot paw edema in mice
Blank paw
Physalin A in Carr-induced Edema Indo. in Carr-induced Edema
Carr-induced Edema
Summary 2
1.
In
in vitro
tests, RAW264.7 macrophages were treated
with physalin A together with LPS, a significant
concentration-dependent inhibition of
NO
production
was detected.
2.
Western blotting revealed that physalin A blocked the
protein expression of
iNOS, COX-2, Ikk, NF-κB, and
MMP-9
in LPS-stimulated RAW264.7 macrophages,
significantly.
3.
Physalin A also inhibited LPS-induced
ERK, and JNK
phosphorylation.
4.
In
in vivo
tests, physalin A decreased the paw edema
at the 4
th
and the 5
th
h after λ-carrageenan
administration, that physalin A significantly attenuated
the
iNOS level
and
edema
in the mice hind paw at the
3
th
-5
th
h after λ-carrageenan injection.
49